tirzepatide before and after weight loss 3 months vs. 6 months on Tirzepatide | REVO Weight Loss
Description
PLoS ONE (2012) 7:e50117
[DOI] [PubMed] [Google Scholar] 126.Axley P, Ahmed Z, Arora S, et al
For type 2 diabetes patients without a previous cannabis use disorder diagnosis, the incidence rate of cannabis use disorder was significantly lower in the semaglutide group (0.21%) compared to the non-GLP-1 receptor agonist medication group (0.48%)
For instance, Fresenius Medical Care AG & Co
Some patients successfully maintain results by switching to a lower, maintenance dose of semaglutide rather than stopping entirely
Weight loss is a side effect of this process
